Federal cabinet approves first license for industrial, medical use of hemp

A stand showcasing cannabidiol (CBD) oil products at the Department of Development of Thai Traditional and Alternative Medicine in Bangkok on Jan. 6, 2020. (AFP/File)
Short Url
Updated 01 September 2020
Follow

Federal cabinet approves first license for industrial, medical use of hemp

  • The license will be issued to the Ministry of Science and Technology and Pakistan Council of Scientific and Industrial Research
  • Since cannabis is illegal in much of the world, the legal status of cannabis-derived compounds is not always certain

ISLAMABAD: Federal Minister for Science and Technology Fawad Hussain Chaudhry announced on Tuesday that the cabinet had approved the first license for industrial and medical use of hemp, a specific variety of cannabis plant. 

Hemp is used to extract a compound called CBD or Cannabidiol that is widely used for medical and therapeutic purposes. Since cannabis is illegal in much of the world, however, the legal status of CBD is not always certain either.
The European Union allows the sale of CBD in most of its member states under strict regulations.
The Food and Drug Administration (FDA) in the United States says on its website that it “recognizes the potential opportunities that cannabis or cannabis-derived compounds may offer and acknowledges the significant interest in these possibilities.”
However, the FDA “is aware that some companies are marketing products containing cannabis and cannabis-derived compounds in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act) and that may put the health and safety of consumers at risk.”
The website adds that the agency is “committed to protecting the public health while also taking steps to improve the efficiency of regulatory pathways for the lawful marketing of appropriate cannabis and cannabis-derived products.”
In Pakistan, a large number of people prefer herbal and traditional medical treatments to more advanced scientific ones since they assume that herbal cures do not have side effects.
Many of these individuals also use CBD that is usually extracted at home.
With the federal cabinet’s decision to allow the Ministry of Science and Technology and the Pakistan Council of Scientific and Industrial Research (PCSIR) to carry out the activity under license, people favoring herbal medicines might benefit from the decision, though the science minister did not give further details in his Twitter post.


Pakistan’s Mahnoor Omer named among TIME’s ‘Women of the Year’ for 2026

Updated 8 sec ago
Follow

Pakistan’s Mahnoor Omer named among TIME’s ‘Women of the Year’ for 2026

  • Omer moved a Pakistani court against the so-called ‘period tax’ in Sept. 2025 which has since sparked a national debate
  • Taxes on sanitary pads in Pakistan can add up to 40 percent to retail price, UNICEF says only around 12 percent women use such products

ISLAMABAD: Pakistani women’s rights activist Mahnoor Omer, who fought against taxes on menstrual products, has been named among the TIME magazine’s ‘Women of the Year’ for 2026.

Omer’s efforts have been recognized alongside 16 activists, artists, athletes and businesswomen in the TIME’s Women of the Year 2026 list, including Olympic gold medalist Sydney McLaughlin-Levrone and Oscar-nominated filmmaker Chloe Zhao.

Dissatisfied with the efforts to educate Pakistani girls about sexual violence, Omer founded the Noor Foundation at the age of 14 and held her own workshops with village girls about everything from climate change to menstruation, according to the TIME magazine.

Two years later, a conversation with a domestic worker about the price of pads made her realize that not everyone could afford these essentials. She moved a court against the so-called “period tax” in Sept. 2025 and the case has sparked a national debate on the subject, considered a taboo by many in Pakistan, since its first hearing late last year.

“A decade and one law degree after her interest in activism was sparked, Omer, now 25, is putting her passion and expertise to work in the name of gender equity,” TIME wrote about Omer on its website.

Taxes imposed on sanitary products in Pakistan can add up to 40 percent to the retail price. UNICEF estimates just 12 percent of women in the country use commercially produced pads or tampons. The alternative, using cloth, risks health impacts including rashes and infections, and can make it impossible for girls to attend school while menstruating.

Omer’s suit, which awaits the government response, has sparked a national discussion. She says she spoke about menstruation to her father and male cousins, who thanked her for standing up for their daughters.
The 25-year-old, who is currently enrolled in a master’s degree in gender, peace, and security at the London School of Economics, sees this case as just the first of many.

“I’m not free until every woman is free,” she was quoted as saying by TIME. “I want to leave no stones unturned in terms of what I can do with the next few decades, as a lawyer for the women in my country and gender minorities in general.”